MARKET

SNYNF

SNYNF

Sanofi FR
OTCPK
83.68
NaN%
Closed 09:30 09/29 EDT
OPEN
--
PREV CLOSE
79.96
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
98.26
52 WEEK LOW
79.96
MARKET CAP
100.25B
P/E (TTM)
22.47
1D
5D
1M
3M
1Y
5Y
1D
Sanofi (SNYNF) Receives a Buy from Deutsche Bank
TipRanks · 20h ago
Weekly Report: what happened at SNYNF last week (0921-0925)?
Weekly Report · 1d ago
Novo Nordisk: Capital Markets Day Reveals Its Next Growth Engine
Seeking Alpha · 5d ago
Trump Trade: U.S. announces deal with Denmark over Greenland’s security
TipRanks · 09/21 14:16
Weekly Report: what happened at SNYNF last week (0914-0918)?
Weekly Report · 09/21 09:46
Itepekimab COPD Extension Trial Completion: What It Means for Regeneron and Sanofi
TipRanks · 09/18 16:30
U.S. weighs allowing most pharma licensing deals with China, Reuters says
TipRanks · 09/18 14:40
Trump administration is said to weigh allowing most pharma licensing deals with China
Seeking Alpha · 09/18 11:08
More
About SNYNF
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA stock information, including OTCPK: SNYNF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNYNF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNYNF stock methods without spending real money on the virtual paper trading platform.